That's right
"With the continued uncertainty of the outcome of the hearing for shareholders, including the opportunity cost of the management team being distracted from value creating opportunities currently under consideration, as well as the necessity to incur substantial legal costs if the matter proceeds to hearing, Virtus has decided not to proceed with the acquisition."
- Forums
- ASX - By Stock
- VRT
- News: VRT ACCC Says It Is Likely To Seek To Discontinue Proceedings On Virtus Health-Fertility Deal
News: VRT ACCC Says It Is Likely To Seek To Discontinue Proceedings On Virtus Health-Fertility Deal, page-4
Featured News
Add VRT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online